161 related articles for article (PubMed ID: 9398889)
1. Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Mégraud F; Malfertheiner P
Helicobacter; 1996 Jun; 1(2):118-21. PubMed ID: 9398889
[No Abstract] [Full Text] [Related]
2. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Helicobacter pylori infection: a review of the world literature.
van der Hulst RW; Keller JJ; Rauws EA; Tytgat GN
Helicobacter; 1996 Mar; 1(1):6-19. PubMed ID: 9398908
[TBL] [Abstract][Full Text] [Related]
4. The role of antisecretory drugs in the treatment of Helicobacter pylori infection.
Peterson WL
Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():21-5. PubMed ID: 9146787
[TBL] [Abstract][Full Text] [Related]
5. Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Rokkas T; Sechopoulos P; Robotis J; Pistiolas D
Am J Gastroenterol; 2006 Aug; 101(8):1938; author reply 1938-9. PubMed ID: 16928256
[No Abstract] [Full Text] [Related]
6. Bismuth-based quadruple therapy for Helicobacter pylori - a single triple capsule plus lansoprazole.
De Boer WA; Van Etten RJ; Van De Wouw BA; Schneeberger PM; Van Oijen AH; Jansen JB
Aliment Pharmacol Ther; 2000 Jan; 14(1):85-9. PubMed ID: 10632650
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Harford W; Lanza F; Arora A; Graham D; Haber M; Weissfeld A; Rose P; Siepman N
Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875
[TBL] [Abstract][Full Text] [Related]
8. Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report.
Schwartz H; Krause R; Siepman N; Haber M; Weissfeld A; Kidd S; Rose P; Sahba B
Helicobacter; 1996 Dec; 1(4):251-5. PubMed ID: 9398876
[TBL] [Abstract][Full Text] [Related]
9. Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication.
Scott BB
Aliment Pharmacol Ther; 1998 Mar; 12(3):277-9. PubMed ID: 9570263
[TBL] [Abstract][Full Text] [Related]
10. New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial.
Xie Y; Pan X; Li Y; Wang H; Du Y; Xu J; Wang J; Zeng Z; Chen Y; Zhang G; Wu K; Liu D; Lv N
J Antimicrob Chemother; 2018 Jun; 73(6):1681-1687. PubMed ID: 29596646
[TBL] [Abstract][Full Text] [Related]
11. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Fennerty MB
Am J Gastroenterol; 1998 Jan; 93(1):2-3. PubMed ID: 9448162
[No Abstract] [Full Text] [Related]
12. Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Tankovic J; Lamarque D; Lascols C; Soussy CJ; Delchier JC
Pathol Biol (Paris); 2001 Sep; 49(7):528-33. PubMed ID: 11642014
[TBL] [Abstract][Full Text] [Related]
13. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
[TBL] [Abstract][Full Text] [Related]
14. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin.
Jaup BK
Helicobacter; 1996 Dec; 1(4):260-1. PubMed ID: 9398878
[No Abstract] [Full Text] [Related]
15. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM
Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
[TBL] [Abstract][Full Text] [Related]
16. [PPI plus bismuth-based quintuple therapy].
Kimura K; Hiratsuka T; Tamura K; Hiratsuka H; Suzuki T; Bray R
Nihon Rinsho; 2005 Nov; 63 Suppl 11():452-8. PubMed ID: 16363577
[No Abstract] [Full Text] [Related]
17. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
18. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
[TBL] [Abstract][Full Text] [Related]
19. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Gisbert JP; Castro-Fernández M; Bermejo F; Pérez-Aisa A; Ducons J; Fernández-Bermejo M; Bory F; Cosme A; Benito LM; López-Rivas L; Lamas E; Pabón M; Olivares D;
Am J Gastroenterol; 2006 Feb; 101(2):243-7. PubMed ID: 16454825
[TBL] [Abstract][Full Text] [Related]
20. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
